Equity Details
Price & Market Data
Price: $20.00
Daily Change: -$0.36 / 1.80%
Daily Range: $19.72 - $20.92
Market Cap: $1,183,657,472
Daily Volume: 170,954
Performance Metrics
1 Week: 2.62%
1 Month: -9.67%
3 Months: -15.97%
6 Months: 43.16%
1 Year: 97.43%
YTD: 4.33%
About DBV Technologies S.A. (DBVT)
Access updated market data for DBV Technologies S.A. (DBVT). Current price: 20.00, daily change: -$0.36 / 1.80%. Market cap: 1,183,657,472. Performance over 1-week, 1-month, and 3-month.
Company Details
Employees: 125
Sector: Health technology
Industry: Pharmaceuticals: major
Country: France
Details
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.